GlassScriptPhysician profile
Mohammed Imran Khan
NPI 1891982278
$4,667.43
in general payments reported to CMS, 2019-2025
15 companies · $508 in 2025
The $508 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $960 · 2020: $478 · 2021: $353 · 2022: $143 · 2023: $1,577 · 2024: $648 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,871 · Food and Beverage: $847 · Gift: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,871.40 |
| Food and Beverage | $847.35 |
| Gift | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genesys Orthopedics Systems, L.L.C. | $1,403.23 | 2023 | Sacroiliac Joint Fusion System |
| Vertiflex, INC. | $891.37 | 2019 | |
| Abbott Laboratories | $614.73 | 2024-2025 | Proclaim, Eterna |
| Relievant Medsystems, INC. | $519.72 | 2020-2023 | Intracept |
| Boston Scientific Corporation | $429.24 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Medtronic, INC. | $374.15 | 2021-2023 | Intellis Adaptivestim |
| Globus Medical, INC. | $280.79 | 2025 | Senza, Omnia |
| Nevro Corp. | $36.59 | 2019-2024 | Senza |
| Stryker Corporation | $25.34 | 2025 | Mild Device Kit |
| Bioventus LLC | $20.67 | 2019 | |
| Medtronic USA, INC. | $17.47 | 2019 | |
| Fidia Pharma USA INC. | $15.20 | 2023 | Hymovis, Triluron |
| Astrazeneca Pharmaceuticals LP | $14.85 | 2019 | |
| Glaxosmithkline, LLC. | $12.45 | 2020 | |
| Sage Therapeutics, LLC | $11.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.